Skip to content
drillr.ai
Sign up

TELO

Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ · Healthcare · Biotechnology · US

$1.16
+0.00%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—————
Gross Profit—————
Operating Expenses
R&D Expense3.0M2.4M2.2M1.6M833.2K
SG&A Expense3.1M8.1M9.6M600.2K20.9K
General & Admin Expense3.1M8.1M9.6M600.2K20.9K
Selling & Marketing Expense—————
Other Expenses——370.5K1.8M—
Total Operating Expenses6.1M10.5M12.2M3.9M854.1K
Cost and Expenses6.1M10.5M12.2M3.9M854.1K
Operating Income (EBIT)(6.1M)(10.5M)(12.2M)(3.9M)(854.1K)
Non-Operating
Interest Income214.1K125.6K48.0K——
Interest Expense7.0K—(4.3M)1.6M—
Net Interest Income207.1K125.6K4.4M(1.6M)—
Other Non-Op Income/Expense211.2K125.6K(4.3M)(9.1M)0.00
Non-Operating Income (excl Interest)(216.8K)(125.6K)(48.0K)7.5M(0.00)
EBT (Pre-Tax Income)(5.9M)(10.4M)(16.5M)(13.1M)(854.1K)
Income Tax Expense—————
Bottom Line
Net Income(5.9M)(10.4M)(16.5M)(13.1M)(854.1K)
Earnings from Cont. Ops(5.9M)(10.4M)(16.5M)(13.1M)(854.1K)
Earnings from Discont. Ops—————
Bottom Line Net Income(52.0M)(10.4M)(16.5M)(13.1M)(854.1K)
Per Share
Basic EPS($1.51)($0.33)($0.56)($0.44)($0.03)
Diluted EPS($1.51)($0.33)($0.56)($0.44)($0.03)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding34.4M31.7M29.5M29.6M29.6M
Diluted Shares Outstanding34.4M31.7M29.5M29.6M29.6M
Profitability Metrics
EBITDA(5.9M)(10.4M)48.0K(11.4M)—
D&A——12.2M—854.1K
EBIT(5.9M)(10.4M)(12.2M)(11.4M)(854.1K)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026